RT Book, Section A1 Anderson, Katherine Vogel A1 Honaker, Sarah E. A2 Whalen, Karen A2 Hardin, Heather C. SR Print(0) ID 1150198464 T1 Atrial Fibrillation MTM Data Set T2 Medication Therapy Management: A Comprehensive Approach, 2e YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9781260108453 LK accesspharmacy.mhmedical.com/content.aspx?aid=1150198464 RD 2024/10/16 AB KEY POINTSAtrial fibrillation (AF) is a common supraventricular tachycardia.The management of AF centers on rate and/or rhythm control and prevention of stroke.Risk of thromboembolic stroke must be assessed in every patient with AF so that appropriate preventive measures can be implemented. Medication therapy management (MTM) providers should be familiar with risk assessment tools and strategies for stroke prevention.Medications used for stroke prevention, rate control, and rhythm control in AF have many important drug interactions (eg, warfarin, amiodarone). MTM providers should be vigilant for drug interactions in patients with AF and, when possible, recommend alternative therapies for other disorders that minimize the risk of significant interactions.